Small Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization
Small Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance
Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.
There are 24 small cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap between $250M and $2B — worth a combined $21.2B.
The largest by market cap are Eton Pharmaceutcials (ETON) at $1.8B, Alvotech (ALVO) at $1.8B and ANI Pharmaceuticals (ANIP) at $1.74B.
Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q2 2026: 55 funds opened new positions, taking total fund holders up 49 (42%) quarter-over-quarter.
- Combined market cap: $21.2B across 24 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: Eton Pharmaceutcials (ETON), $1.8B market cap.
- Most net new fund positions in Q2 2026: Eton Pharmaceutcials (ETON), +49 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.